Answer
The safety and efficacy of Tepkinly (epcoritamab) in children under 18 have not yet been established, and no data are available.
Sources for this answer
- Tepkinly 4 mg/0.8 ml solution for injectionAbbVie Ltd · emc · SmPC §4.2 Posology and method of administration · Version 11Document updated
Sources checked